Featured Research

from universities, journals, and other organizations

Diabetes drug may reduce brain damage after stroke

Date:
December 4, 2012
Source:
Karolinska Institutet
Summary:
In a study in mice, scientists in Sweden have discovered a new potential therapy that may reduce brain damage following stroke in type 2 diabetic patients. The suggested drug is already approved for the treatment of type 2 diabetes. However, the scientists hope that this new results also opens up the possibility to decrease brain injury after stroke in other patient groups with a high stroke risk.

In a study in mice, scientists at Karolinska Institutet in Sweden have discovered a new potential therapy that may reduce brain damage following stroke in type 2 diabetic patients. The suggested drug is already approved for the treatment of type 2 diabetes. However, the scientists hope that this new results, presented in the scientific journal Diabetes, also opens up the possibility to decrease brain injury after stroke in other patient groups with a high stroke risk.

Stroke is when part of the neural tissue in the brain is damaged due to lack of oxygen delivery, either caused by a blood clot (thrombosis) or rupture of a blood vessel. People suffering from diabetes are at higher risk to develop stroke than the average population. The only acute treatment to decrease the consequences (disability) of a stroke commonly available is thrombolysis, which dissolves the blood clot in the occluded vessels of the brain when quickly administered after onset of symptoms.

However, this therapy is only available for approximately 10 per cent of stroke patients and has potential severe side effects, mainly brain hemorrhage. Furthermore, the effect of thrombolysis treatment is reduced in diabetic patients as diabetes in itself causes a sensitive vessel structure.

The chemical substance at the basis of the current finding is called linagliptin, and is already commercialized as an antidiabetic drug under a trade name. Combined with exercise and special diet, linagliptin lowers the levels of glucose in the blood in adults with type 2 diabetes. In their study, the scientists administered linagliptin or placebo to diabetic mice, before and after having induced a stroke experimentally. By using this study design, the scientists simulated the situation of type 2 diabetic patients under the treatment of linagliptin.

The results show that linagliptin is able to stimulate neuroprotection and largely reduce the brain damage following stroke, independent of its glucose-lowering effects. This in turn suggests that type 2 diabetic patients, when treated with linagliptin, might have a better prognosis after a stroke than diabetics receiving other treatments.

The current study is the result of a collaborative effort between scientists at the Department of Clinical Science and Education, the Stockholm South General Hospital (Södersjukhuset), and the pharmaceutical company Boehringer Ingelheim Pharma GmbH & Co. The work was conceived and directed by Dr Cesare Patrone and Professor Åke Sjöholm, while Dr Vladimer Darsalia led the experiments of the study.


Story Source:

The above story is based on materials provided by Karolinska Institutet. Note: Materials may be edited for content and length.


Journal Reference:

  1. V. Darsalia, H. Ortsater, A. Olverling, E. Darlof, P. Wolbert, T. Nystrom, T. Klein, A. Sjoholm, C. Patrone. The DPP-4 Inhibitor Linagliptin Counteracts Stroke in the Normal and Diabetic Mouse Brain: A Comparison With Glimepiride. Diabetes, 2012; DOI: 10.2337/db12-0988

Cite This Page:

Karolinska Institutet. "Diabetes drug may reduce brain damage after stroke." ScienceDaily. ScienceDaily, 4 December 2012. <www.sciencedaily.com/releases/2012/12/121204081232.htm>.
Karolinska Institutet. (2012, December 4). Diabetes drug may reduce brain damage after stroke. ScienceDaily. Retrieved July 28, 2014 from www.sciencedaily.com/releases/2012/12/121204081232.htm
Karolinska Institutet. "Diabetes drug may reduce brain damage after stroke." ScienceDaily. www.sciencedaily.com/releases/2012/12/121204081232.htm (accessed July 28, 2014).

Share This




More Health & Medicine News

Monday, July 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Trees Could Save More Than 850 Lives Each Year

Trees Could Save More Than 850 Lives Each Year

Newsy (July 27, 2014) — A national study conducted by the USDA Forest Service found that trees collectively save more than 850 lives on an annual basis. Video provided by Newsy
Powered by NewsLook.com
Google's Next Frontier: The Human Body

Google's Next Frontier: The Human Body

Newsy (July 27, 2014) — Google is collecting genetic and molecular information to paint a picture of the perfectly healthy human. Video provided by Newsy
Powered by NewsLook.com
What's To Blame For Worst Ebola Outbreak In History?

What's To Blame For Worst Ebola Outbreak In History?

Newsy (July 27, 2014) — A U.S. doctor has tested positive for the deadly Ebola virus, as the worst-ever outbreak continues to grow. Video provided by Newsy
Powered by NewsLook.com
Losing Sleep Leaves You Vulnerable To 'False Memories'

Losing Sleep Leaves You Vulnerable To 'False Memories'

Newsy (July 27, 2014) — A new study shows sleep deprivation can make it harder for people to remember specific details of an event. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins